UPDATE : Thursday, June 20, 2019
‘Pseudoephedrine-containing drugs could cause acute skin reaction’ 
The government is likely to add a warning in the instructions of pseudoephe...
by Lee Hye-seon  |  2019-01-31 14:34
Kwangdong dismisses rumors of terminating sales for Contrav
Kwangdong Pharmaceutical denied Thursday rumors of the company stopping sal...
by Lee Han-soo  |  2019-01-31 14:32
Ipsen’s renal cancer drug Carbometyx gets insurance benefit
Ipsen Korea’s advanced renal cell carcinoma treatment Carbometyx (cabozanti...
by Park Gi-taek  |  2019-01-31 11:13
₩4.7 billion spent on compensation for side effect injuries in 4 years
Korea used 4.74 billion won ($4.24 million) to compensate the damages such ...
by Lee Hye-seon  |  2019-01-30 17:18
Pfizer’s lung cancer drug Xalkori threatened by new rivals
Pfizer’s Xalkori (ingredient: crizotinib) has been solidifying its status a...
by Kim Yun-mi  |  2019-01-30 12:34
Biogen, NHIS begin price talk for spinal muscular atrophy treatment
The National Health Insurance Service (NHIS) and Biogen started price negot...
by Lee Han-soo  |  2019-01-30 11:43
GC to stop making 1st thrombolytic agent amid poor sales
GC will stop manufacturing Urokinase, Korea’s first thrombolytic agent, aft...
by Lee Han-soo  |  2019-01-29 16:44
Sanofi gets nod to increase dosage for multiple sclerosis treatment
Sanofi Genzyme Korea said that the Ministry of Food and Drug safety has exp...
by Lee Han-soo  |  2019-01-28 17:02
BMS withdraws Opdivo application for TMB high lung cancer in US
Bristol-Myers Squibb (BMS) said Thursday that it had voluntarily pulled its...
by Lee Han-soo  |  2019-01-28 15:25
ISU Abxis confirms safety profile for immunotherapy candidate
ISU Abxis has published an interim report confirming the safety profile for...
by Lee Han-soo  |  2019-01-28 14:34
4 local firms win exclusive rights to sell Pradaxa’s generic copies
The Supreme Court recently ruled that drugmakers’ alteration of an original...
by Lee Hye-seon  |  2019-01-28 11:56
Humedix to supply osteoarthritis treatment to Huons, Shin Poong
Humedix said Thursday that it has signed an agreement to supply, sell and l...
by Lee Han-soo  |  2019-01-24 18:11
US sales of J&J’s Remicade sink due to biosimilars’ challenge
The U.S. sales of Johnson & Johnson's (J&J) Remicade, a blockbuster ant...
by Lee Han-soo  |  2019-01-24 11:44
Kanzen, Corea Therapeutics to co-develop next-generation anticancer immune cell therapy
Kanzen said Tuesday that it has signed an agreement with Corea Therapeutics...
by Lee Han-soo  |  2019-01-23 21:29
Court rejects patent registration for acute myeloid leukemia drug Vyxeos
The Patent Court of Korea has rejected Jazz Pharmaceuticals’ application fo...
by Lee Hye-seon  |  2019-01-23 14:47
Lilly returns rights for Hanmi’s BTK inhibitor candidate
Hanmi Pharmaceutical said Wednesday that Lilly has returned licensing right...
by Lee Han-soo  |  2019-01-23 10:21
Bridge Biotherapeutics licenses in new targeted thearpy candidate
Bridge Biotherapeutics said Wednesday that it has signed a technology trans...
by Lee Han-soo  |  2019-01-23 10:20
Chong Kun Dang to co-promote CJ Healthcare’s gastroesophageal reflux treatment
CJ Healthcare said Tuesday that it has signed an agreement with Chong Kun D...
by Lee Han-soo  |  2019-01-22 16:03
Drug distributors to report Novo Nordisk to antitrust watchdog over ‘unfair trade’
The Korea Pharmaceutical Distribution Association (KPDA) is seeking to file...
by Park Gi-taek  |  2019-01-22 14:18
BMS, Ono Pharma wins more indication for Opdivo in EU
Bristol-Myers Squibb (BMS) and Ono Pharma Korea have received an additional...
by Lee Han-soo  |  2019-01-21 18:01
Back to Top